Purpose: This study was designed to determine the feasibility and safety of ultrasound-guided transhepatic radiofrequency ablation (RFA) of masses in the right kidney.

Methods: Between June 2001 and December 2011, 18 patients who underwent transhepatic renal RFA procedures to treat 19 tumors were retrospectively identified. Complications (Clavien-Dindo classification system) and local tumor control were evaluated for all patients.

Results: Median maximal diameter of the treated renal tumors was 1.9 (range 1.1-4.3) cm. No major complication developed during any of the procedures. No hepatic tumor seeding was identified during imaging follow-up. There was a single technical failure (5.3%). Median cross-sectional imaging follow-up was 28 (range 3-121) months. Primary technique failure (local recurrence) occurred in 1 of the 16 tumors with follow-up imaging (5.3%).

Conclusions: Percutaneous ultrasound-guided transhepatic RFA of renal neoplasms is technically feasible, effective, and associated with a low rate of complications. The transhepatic approach may allow safe ablation of renal tumors that would otherwise be difficult to treat.

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00270-013-0716-xDOI Listing

Publication Analysis

Top Keywords

ultrasound-guided transhepatic
12
renal tumors
12
transhepatic radiofrequency
8
radiofrequency ablation
8
ablation renal
8
imaging follow-up
8
renal
5
tumors
5
tumors safe
4
safe effective
4

Similar Publications

Advances in minimally invasive treatment of malignant obstructive jaundice.

World J Gastrointest Surg

December 2024

Department of Outpatient, Puer People's Hospital, Puer 665000, Yunnan Province, China.

Malignant obstructive jaundice (MOJ) encompasses a range of diseases stemming from malignant tumors such as cholangiocarcinoma, pancreatic cancer, and primary liver cancer, among others, which cause obstruction in both intra- and extra-hepatic bile ducts. This obstruction may lead to elevated bilirubin levels, hepatic function impairment, and a low rate of successful surgical resection in clinical settings. There are various minimally invasive treatment options for MOJ, including endoscopic biliary drainage, ultrasound-guided procedures, and percutaneous biliary tract puncture drainage.

View Article and Find Full Text PDF

Technical Note on Modified Direct Intrahepatic Portocaval Shunt Targeting Different Vessels for Portal Vein Obstruction in Cirrhosis.

Cardiovasc Intervent Radiol

January 2025

Department of Gastroenterology and Hepatology, Zhongnan Hospital of Wuhan University, No. 169, Donghu Road, Wuchang District, Wuhan, 430071, Hubei Province, China.

Purpose: This study aimed to explore a modified direct intrahepatic portocaval shunt (DIPS) technique as an alternative approach for patients with portal vein occlusion (PVO) and cirrhosis who were not candidates for traditional transjugular intrahepatic portosystemic shunt (TIPS) due to anatomical challenges.

Technique: Three patients with esophageal or gastric fundus variceal hemorrhage complicated by severe PVO were treated using innovative DIPS approaches. Preoperative contrast-enhanced computed tomography was employed to assess anatomical feasibility.

View Article and Find Full Text PDF

Endoscopic ultrasound-guided biliary drainage percutaneous transhepatic biliary drainage for malignant biliary obstruction after endoscopic retrograde cholangiopancreatography failure.

World J Gastrointest Surg

November 2024

Department of Interventional Therapy, National Cancer Center, National Clinical Research Center for Cancer, Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China.

In a recent issue of the , a meta-analysis investigated the safety and efficacy of electrocautery-enhanced lumen-apposing metal stent (ECE-LAMS) implantation for managing malignant biliary obstruction following failed endoscopic retrograde cholangiopancreatography. This manuscript endeavors to offer a comprehensive look at the progression of endoscopic ultrasound-guided biliary drainage (EUS-BD) technologies, weighing their merits and drawbacks against traditional percutaneous methods. Several meta-analyses and randomized controlled trials have compared the performance of EUS-BD and percutaneous transhepatic cholangiodrainage (PTCD).

View Article and Find Full Text PDF
Article Synopsis
  • Cholecystectomy is the standard treatment for average-risk patients with acute cholecystitis, but high-risk patients may benefit from alternatives like PT-GBD and EUS-GBD.
  • PT-GBD has limitations and is not suitable for every patient, especially those too ill to be transferred, making bedside EUS-GBD a viable option.
  • A case series showed that bedside EUS-GBD in the ICU was safe and effective for critically ill patients, but all required comfort care due to their serious conditions, suggesting the need for more research in this area.
View Article and Find Full Text PDF

Changes over time in treatment for obstructive jaundice.

World J Gastrointest Surg

October 2024

Department of Surgery, National Hospital Organization Iwakuni Clinical Center, Iwakuni 740-8510, Yamaguchi, Japan.

Article Synopsis
  • The editorial reviews an article by Peng that examines a new method for treating obstructive jaundice, focusing on its efficacy and safety.
  • It highlights the two main issues with obstructive jaundice: cholestatic status and lack of bile flow, both of which were addressed through internal biliary drainage.
  • The piece discusses the shift from percutaneous transhepatic biliary drainage to endoscopic retrograde biliary drainage (ERBD) and the emerging role of endoscopic ultrasound-guided biliary drainage in treatment.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!